Removal of carbapenem-Resistant enterobacteriaceae (CRE) from Blood by heparin-Functional hemoperfusion media

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Mccrea, Keith ^a   Ward, Robert ^b   Larosa, Steven P ^a  

^a ExThera Medical Corporation   (United States)

^b Beverly Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; HEPARAN SULFATE; ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; HEPARIN;

ADSORPTION; ARTICLE; BIOMIMETIC DEVICE; BLOOD; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; COVALENT BOND; CULTURE MEDIUM; ESCHERICHIA COLI; GENERAL DEVICE; HEMOPERFUSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MATERIAL COATING; MOLECULAR WEIGHT; NONHUMAN; ANIMAL; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIUM ADHERENCE; CHEMISTRY; HORSE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES;

ADSORPTION; ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL ADHESION; BETA-LACTAM RESISTANCE; CARBAPENEMS; ESCHERICHIA COLI; HEMOPERFUSION; HEPARIN; HORSES; HUMANS; KLEBSIELLA PNEUMONIAE;

EID: 84955063698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114242     Document Type: Article

References (9)

1. Arnold RS, Thom KA, Sharma S, Phillips M, Johnson JK, et al. (2011)Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria. Southern Med J 104 (1): 40-45.
2. Centers for Disease Control and Prevention (2013) Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR 62: 165-170.
3. Larm O, Larsson R, Olsonn P (1983) A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs 11: 161- 173.
4. Sahly J, Navon-Venezia S, Roesler L, Hay A, Carmeli Y, et al. (2008)Extended-Spectrum B-lactamase Production is Associated with an Increase in Cell Invasion and Expression of Fimbrial Adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother 52(9): 3029-34.
5. Mattsby-Baltzer I, Bergstrom T, McCrea K, Ward R, Adolfsson L, et al. (2011) Affinity Apheresis for Treatment of Bacteremia caused by Staphylococcus aureus and/or Methicillin-Resistant S. aureus (MRSA). J Microbiol Biotechnol 21 (96): 659-664.
6. Bartlett AH, Park PW (2011)Heparan Sulfate Proteoglycans in Infection. In: Pavao MSG, editor. Glycans in Diseases and Therapeutics.Berlin: Springer-Verlag. pp. 31-62.
7. Falagas ME, Lourdida P, Pouulikakos P, Rafallidis PI, Tansarli G (2014) Antibiotic Treatment of Infections Due to Carbapenem -Resistant Enterobactericeae: Systematic Evaluation of the Available Evidence. Antimicrob Agents Chemother 58(2): 654-63.
8. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, et al. (2012)Outcome of carbapenem resistant Klebsiella pneumonia bloodstream infections. Clin Microbiol Infect 18: 54-60.
9. Neuner EA, Yeh JY, Hall GS, Sekeres J, Endiamani A, et al. (2011) Treatment and outcomes in Carbapenem-resistant Klebsiella pneumoniae Bloodstream Infections. Diagn Microbiol Infect Dis 69 (4): 357-362.